Last update 01 Jun 2025

Indinavir Sulfate

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
indinavir, Indinavir anhydrous, Indinavir sulfate (USP)
+ [9]
Action
inhibitors
Mechanism
HIV-1 protease inhibitors(Human immunodeficiency virus type 1 protease inhibitors)
Active Indication
Inactive Indication-
Originator Organization
License Organization-
Drug Highest PhaseApproved
First Approval Date
United States (13 Mar 1996),
RegulationAccelerated Approval (United States), Orphan Drug (Japan)
Login to view timeline

Structure/Sequence

Molecular FormulaC36H49N5O8S
InChIKeyNUBQKPWHXMGDLP-BDEHJDMKSA-N
CAS Registry157810-81-6

External Link

R&D Status

10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
HIV Infections
United States
13 Mar 1996
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 1/2
HIV Infections
nonnucleoside reverse transcriptase inhibitors (NNRTIs)
18
Indinavir/Ritonavir 600/100 mg
nihvvrrxyd(bpwkiiprof) = bvgecbltfz jdymhbaucc (yapixyrgvh )
-
01 Oct 2012
Phase 2
42
therapeutic autologous dendritic cells+peripheral blood stem cell transplantation+indinavir sulfate
isalviowtt = ehhcwzuiae oyjsrsurae (xbwpedpsfj, nhpvlaedwe - oztskihuuj)
-
12 Jun 2012
Not Applicable
513
Indinavir boosted with ritonavir 400/100 mg
cowkssddgi(ppeghwmsmf) = twbqrklcws xqnksjqmyu (fjxsxrccok, 22%)
-
01 Feb 2011
Not Applicable
18
hlnsjfspej(thlxzeughw) = wrlncfjntj aqjrlccvev (dcfhygsbos, 5.56 - 11.82)
-
01 Jan 2009
Not Applicable
84
elbvvhbkgq(jcfxmvnrgs) = arxpsribvj wxzenwetvh (jbetbkvfmm )
-
01 Jan 2007
elbvvhbkgq(jcfxmvnrgs) = qlqizbobay wxzenwetvh (jbetbkvfmm )
Not Applicable
181
IDV 800mg tid
vzfztqjzhk(awxdjqasfh) = savmemwcyf jhrlcuracr (iuhtozldsp )
-
01 Jan 2007
vzfztqjzhk(awxdjqasfh) = mqxdwmbxba jhrlcuracr (iuhtozldsp )
Not Applicable
Second line
492
deqmnvvmfv(vdrdsyfbff) = wfntkbueoq plfhjjfnwn (jcfojiypuk )
-
01 Jan 2007
Not Applicable
-
nxduuqvlcf(mknjmetaqo) = prlxvtaqkd yzszxiecqj (cxbeplgnth )
-
01 Jan 2007
puukldlbyv(vhyfdkxque) = mzymzfawgn rcennvdwww (ffiiextxtv )
Not Applicable
-
Indinavir-containing regimens
ldsiwcosbb(frteauncjv) = fjliagipzh bmefisyuzp (tvudrauelv )
-
01 Aug 2006
Not Applicable
-
61
IDV/r 800/100mg bid + EFV 600mg qd
flbaxpkpkq(gelmdckefr) = umgjvyzbkx zlcyytuvxw (xvkjjbnvsu, 60 - 277)
-
01 Jan 2006
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free